Search Results 2171-2180 of 21767 for platelets

  1. Evaluating the safety and efficacy of mesenchymal stem cells in the treatment of low back pain - Mayo Clinic

    These therapies include intradiscal injections of biologic agents such as mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP), which are believed ...

  2. Sports Medicine - Doctors - Mayo Clinic

    Areas of focus: Regenerative medicine therapy, Microfragmented fat injection, Ultrasound-guided musculoskeletal injection, Platelet ric...h plasma injection ...

  3. Priapism - Diagnosis & treatment - Mayo Clinic

    Blood drawn from your arm can be tested to measure the number of red blood cells and platelets present. Results might show evidence of diseases, such as ...

  4. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

    Absolute neutrophil count (ANC) > 1,000/mm^3 (µL) & platelet count > 50,000/mm^3 (µL);; Total bilirubin ≤ 1.5 times the upper limit of normal (ULN);; Alanine ...

  5. A Study to Evaluate the Safety and Effectiveness of Intratumoral and Intravenous Injection of Vesicular Stomatitis Virus Expressing Human Interferon Beta, and Tyrosinase Related Protein 1 (VSV-IFNb-TYRP1) in Patients with Metastatic Ocular Melanoma and Previously Treated Patients with Unresectable Stage III/IV Cutaneous Melanoma - Mayo Clinic

    Platelet count ≥ 100,000/mm^3;; Hemoglobin ≥ 9.0 g/dL (without need for hematopoietic growth factor or transfusion support);; Alanine aminotransferase (ALT) ...

  6. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

    Platelet count ≥ 100,000/mm^3;; Hemoglobin > 9.0 g/dL or ≥ 5.6 mmol/L without transfusion or (EPO) erythropoietin dependency (within 7 days of assessment); ...

  7. Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery - Mayo Clinic

    Platelet count ≥ 75,000/mm^3*;; Hemoglobin ≥ 9.0 g/dL;; Total bilirubin ≤ 1.5 X upper limit of normal (ULN); if total bilirubin > 1.5 X ULN then direct ...

  8. Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery - Mayo Clinic

    Platelets ≥ 1 X 10^6 cells/mm^3 (100,000) based upon complete blood count (CBC); Hemoglobin ≥ 10.0 g/dl based upon CBC (Note: The use of transfusion or ...

  9. Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Platelet (PLT) ≥ 75,000/uL; Serum total bilirubin within normal range (or ≤ 1.5 x upper limit of normal [ULN] if liver metastases are present; or total ...

  10. Phase 2 Study Of ALXN2030 In Patients With Antibody-Mediated Rejection After Kidney Transplantation - Mayo Clinic

    * Platelets < 100 × 109/L * Leucocytes < 3 × 109/L * Neutrophils < 1.5 × 109/L * Multiorgan transplant recipient (except for previous multiple kidney ...